Copyright © 2012 Thomas Wurdinger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. E. Cocucci, G. Racchetti, and J. Meldolesi, “Shedding microvesicles: artefacts no more,” Trends in Cell Biology, vol. 19, no. 2, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
2. S. Mathivanan, H. Ji, and R. J. Simpson, “Exosomes: extracellular organelles important in intercellular communication,” Journal of Proteomics, vol. 73, no. 10, pp. 1907–1920, 2010. View at Publisher · View at Google Scholar · View at Scopus
3. M. Simons and G. Raposo, “Exosomes—vesicular carriers for intercellular communication,” Current Opinion in Cell Biology, vol. 21, no. 4, pp. 575–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
4. K. E. van der Vos, L. Balaj, J. Skog, and X. O. Breakefield, “Brain tumor microvesicles: insights into intercellular communication in the nervous system,” Cellular and Molecular Neurobiology, vol. 31, pp. 949–959, 2011. View at Publisher · View at Google Scholar · View at Scopus
5. S. Pant, H. Hilton, and M. E. Burczynski, “The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities,” Biochemical Pharmacology, vol. 83, no. 11, pp. 1484–1494, 2012. View at Publisher · View at Google Scholar · View at Scopus
6. J. Skog, T. Würdinger, S. van Rijn et al., “Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers,” Nature Cell Biology, vol. 10, no. 12, pp. 1470–1476, 2008. View at Publisher · View at Google Scholar · View at Scopus
7. C. Lässer, V. Seyed Alikhani, K. Ekström et al., “Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages,” Journal of Translational Medicine, vol. 9, article 9, 2011. View at Publisher · View at Google Scholar · View at Scopus
8. C. Théry, A. Regnault, J. Garin et al., “Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73,” Journal of Cell Biology, vol. 147, no. 3, pp. 599–610, 1999. View at Publisher · View at Google Scholar · View at Scopus
9. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
10. K. Tamai, N. Tanaka, T. Nakano et al., “Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein,” Biochemical and Biophysical Research Communications, vol. 399, no. 3, pp. 384–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
11. K. Trajkovic, C. Hsu, S. Chiantia et al., “Ceramide triggers budding of exosome vesicles into multivesicular endosomes,” Science, vol. 319, no. 5867, pp. 1244–1247, 2008. View at Publisher · View at Google Scholar · View at Scopus
12. M. Ostrowski, N. B. Carmo, S. Krumeich et al., “Rab27a and Rab27b control different steps of the exosome secretion pathway,” Nature Cell Biology, vol. 12, no. 1, pp. 19–3013, 2010. View at Scopus
13. X. Yu, S. L. Harris, and A. J. Levine, “The regulation of exosome secretion: a novel function of the p53 protein,” Cancer Research, vol. 66, no. 9, pp. 4795–4801, 2006. View at Publisher · View at Google Scholar · View at Scopus
14. A. Savina, C. M. Fader, M. T. Damiani, and M. I. Colombo, “Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner,” Traffic, vol. 6, no. 2, pp. 131–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
15. C. Hsu, Y. Morohashi, S. I. Yoshimura et al., “Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C,” Journal of Cell Biology, vol. 189, no. 2, pp. 223–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
16. K. Al-Nedawi, B. Meehan, J. Micallef et al., “Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells,” Nature Cell Biology, vol. 10, no. 5, pp. 619–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
17. L. Balaj, R. Lessard, L. Dai et al., “Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences,” Nature Communications, vol. 2, article 180, 2011. View at Publisher · View at Google Scholar · View at Scopus
18. K. Schara, V. Janša, V. Šuštar et al., “Mechanisms for the formation of membranous nanostructures in cell-to-cell communication,” Cellular and Molecular Biology Letters, vol. 14, no. 4, pp. 636–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
19. V. Muralidharan-Chari, J. Clancy, C. Plou et al., “ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles,” Current Biology, vol. 19, no. 22, pp. 1875–1885, 2009. View at Publisher · View at Google Scholar · View at Scopus
20. J. F. Nabhan, R. Hu, R. S. Oh, S. N. Cohen, and Q. Lu, “Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 11, pp. 4146–4151, 2012. View at Publisher · View at Google Scholar · View at Scopus
21. R. Contreras-Galindo, M. H. Kaplan, P. Leissner et al., “Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer,” Journal of Virology, vol. 82, no. 19, pp. 9329–9336, 2008. View at Publisher · View at Google Scholar · View at Scopus
22. A. Daskalos, G. Nikolaidis, G. Xinarianos et al., “Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer,” International Journal of Cancer, vol. 124, no. 1, pp. 81–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
23. M. Hristov, W. Erl, S. Linder, and P. C. Weber, “Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro,” Blood, vol. 104, no. 9, pp. 2761–2766, 2004. View at Publisher · View at Google Scholar · View at Scopus
24. W. Lösche, T. Scholz, U. Temmler, V. Oberle, and R. A. Claus, “Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils,” Platelets, vol. 15, no. 2, pp. 109–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
25. B. J. C. Quah, V. P. Barlow, V. McPhun, K. I. Matthaei, M. D. Hulett, and C. R. Parish, “Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4259–4264, 2008. View at Publisher · View at Google Scholar · View at Scopus
26. O. P. Barry, D. Praticò, R. C. Savani, and G. A. FitzGerald, “Modulation of monocyte-endothelial cell interactions by platelet microparticles,” Journal of Clinical Investigation, vol. 102, no. 1, pp. 136–144, 1998. View at Scopus
27. A. Janowska-Wieczorek, M. Majka, J. Kijowski et al., “Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment,” Blood, vol. 98, no. 10, pp. 3143–3149, 2001. View at Publisher · View at Google Scholar · View at Scopus
28. M. Eldh, K. Ekström, H. Valadi et al., “Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA,” PloS One, vol. 5, no. 12, Article ID e15353, 2010. View at Scopus
29. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
30. D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-Lawson et al., “Functional delivery of viral miRNAs via exosomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6328–6333, 2010. View at Publisher · View at Google Scholar · View at Scopus
31. N. Kosaka and T. Ochiya, “Unraveling the mystery of cancer by secretory microRNA: horizontal microRNA transfer between living cells,” Frontiers in Genetics, vol. 2, p. 97, 2011.
32. Q. Zhou, M. Li, X. Wang et al., “Immune-related microRNAs are abundant in breast milk exosomes,” International Journal of Biological Sciences, vol. 8, no. 1, pp. 118–123, 2011. View at Scopus
33. A. Tumne, V. S. Prasad, Y. Chen et al., “Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8⁺ T cells,” Journal of Virology, vol. 83, no. 9, pp. 4354–4364, 2009. View at Publisher · View at Google Scholar · View at Scopus
34. M. Mack, A. Kleinschmidt, H. Brühl et al., “Transfer of the chemokine receptor CCR5 between cells by membrane- derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection,” Nature Medicine, vol. 6, no. 7, pp. 769–775, 2000. View at Publisher · View at Google Scholar · View at Scopus
35. T. Rozmyslowicz, M. Majka, J. Kijowski et al., “Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV,” AIDS, vol. 17, no. 1, pp. 33–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
36. R. D. Wiley and S. Gummuluru, “Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 738–743, 2006. View at Publisher · View at Google Scholar · View at Scopus
37. S. Temme, A. M. Eis-Hübinger, A. D. McLellan, and N. Koch, “The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway,” The Journal of Immunology, vol. 184, no. 1, pp. 236–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
38. W. Xu, P. A. Santini, J. S. Sullivan et al., “HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits,” Nature Immunology, vol. 10, no. 9, pp. 1008–1017, 2009. View at Publisher · View at Google Scholar · View at Scopus
39. C. Muratori, L. E. Cavallin, K. Krätzel et al., “Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells,” Cell Host and Microbe, vol. 6, no. 3, pp. 218–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
40. S. A. Ali, M. B. Huang, P. E. Campbell et al., “Genetic characterization of HIV type 1 nef-induced vesicle secretion,” AIDS Research and Human Retroviruses, vol. 26, no. 2, pp. 173–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
41. M. Lenassi, G. Cagney, M. Liao et al., “HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4⁺ T cells,” Traffic, vol. 11, no. 1, pp. 110–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
42. M. T. Esser, D. R. Graham, L. V. Coren et al., “Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation,” Journal of Virology, vol. 75, no. 13, pp. 6173–6182, 2001. View at Publisher · View at Google Scholar · View at Scopus
43. J. D. Walker, C. L. Maier, and J. S. Pober, “Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4⁺ memory T cells by releasing antigenic exosomes,” The Journal of Immunology, vol. 182, no. 3, pp. 1548–1559, 2009. View at Scopus
44. J. Klibi, T. Niki, A. Riedel et al., “Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells,” Blood, vol. 113, no. 9, pp. 1957–1966, 2009. View at Publisher · View at Google Scholar · View at Scopus
45. J. Flanagan, J. Middeldorp, and T. Sculley, “Localization of the Epstein-Barr virus protein LMP 1 to exosomes,” Journal of General Virology, vol. 84, no. 7, pp. 1871–1879, 2003. View at Publisher · View at Google Scholar · View at Scopus
46. M. K. Gandhi, G. Moll, C. Smith et al., “Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma,” Blood, vol. 110, no. 4, pp. 1326–1329, 2007. View at Publisher · View at Google Scholar · View at Scopus
47. M. Mittelbrunn, C. Gutiérrez-Vázquez, C. Villarroya-Beltri et al., “Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells,” Nature Communications, vol. 2, no. 1, article 282, 2011. View at Publisher · View at Google Scholar · View at Scopus
48. D. J. Dargan and J. H. Subak-Sharpe, “The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA,” Virology, vol. 239, no. 2, pp. 378–388, 1997. View at Publisher · View at Google Scholar · View at Scopus
49. S. Loret, G. Guay, and R. Lippé, “Comprehensive characterization of extracellular herpes simplex virus type 1 virions,” Journal of Virology, vol. 82, no. 17, pp. 8605–8618, 2008. View at Publisher · View at Google Scholar · View at Scopus
50. J. McLauchlan, C. Addison, M. C. Craigie, and F. J. Rixon, “Noninfectious L-particles supply functions which can facilitate infection by HSV-1,” Virology, vol. 190, no. 2, pp. 682–688, 1992. View at Publisher · View at Google Scholar · View at Scopus
51. F. J. Rixon, C. Addison, and J. Mclauchlan, “Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells,” Journal of General Virology, vol. 73, no. 2, pp. 277–284, 1992. View at Scopus
52. B. J. Kelly, C. Fraefel, A. L. Cunningham, and R. J. Diefenbach, “Functional roles of the tegument proteins of herpes simplex virus type 1,” Virus Research, vol. 145, no. 2, pp. 173–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
53. J. Neumann, A. M. Eis-Hübinger, and N. Koch, “Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion,” The Journal of Immunology, vol. 171, no. 6, pp. 3075–3083, 2003. View at Scopus
54. J. M. Silverman and N. E. Reiner, “Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes,” Cellular Microbiology, vol. 13, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
55. B. György, T. G. Szabó, M. Pásztói et al., “Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles,” Cellular and Molecular Life Sciences, vol. 68, no. 16, pp. 2667–2688, 2011. View at Publisher · View at Google Scholar · View at Scopus
56. D. G. Meckes Jr. and N. Raab-Traub, “Microvesicles and viral infection,” Journal of Virology, vol. 85, no. 24, pp. 12844–12854, 2011. View at Publisher · View at Google Scholar · View at Scopus
57. G. Raposo, H. W. Nijman, W. Stoorvogel et al., “B lymphocytes secrete antigen-presenting vesicles,” Journal of Experimental Medicine, vol. 183, no. 3, pp. 1161–1172, 1996. View at Publisher · View at Google Scholar · View at Scopus
58. A. De Gassart, B. Trentin, M. Martin et al., “Exosomal sorting of the cytoplasmic domain of bovine leukemia virus TM Env protein,” Cell Biology International, vol. 33, no. 1, pp. 36–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
59. N. Plazolles, J. M. Humbert, L. Vachot, B. Verrier, C. Hocke, and F. Halary, “Pivotal Advance: the promotion of soluble DC-SIGN release by inflammatory signals and its enhancement of cytomegalovirus-mediated cis-infection of myeloid dendritic cells,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 329–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
60. F. Masciopinto, C. Giovani, S. Campagnoli et al., “Association of hepatitis C virus envelope proteins with exosomes,” European Journal of Immunology, vol. 34, no. 10, pp. 2834–2842, 2004. View at Publisher · View at Google Scholar · View at Scopus
61. A. K. Khatua, H. E. Taylor, J. E. K. Hildreth, and W. Popik, “Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells,” Journal of Virology, vol. 83, no. 2, pp. 512–521, 2009. View at Publisher · View at Google Scholar · View at Scopus
62. Y. V. Liu, M. J. Massare, D. L. Barnard et al., “Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV,” Vaccine, vol. 18, pp. 285–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
63. J. Hardcastle, K. Kurozumi, N. Dmitrieva et al., “Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1,” Molecular Therapy, vol. 18, no. 2, pp. 285–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
64. J. Y. Yoo, A. Haseley, A. Bratasz et al., “Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and vstat120-expressing oncolytic virus,” Molecular Therapy, vol. 20, no. 2, pp. 287–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
65. E. A. Chiocca, “Oncolytic viruses,” Nature Reviews Cancer, vol. 2, no. 12, pp. 938–950, 2002. View at Publisher · View at Google Scholar · View at Scopus
66. C. A. Maguire, L. Balaj, S. Sivaraman et al., “Microvesicle-associated AAV vector as a novel gene delivery system,” Molecular Therapy, vol. 20, no. 5, pp. 960–971, 2012. View at Publisher · View at Google Scholar · View at Scopus
67. J. L. Umbach, M. F. Kramer, I. Jurak, H. W. Karnowski, D. M. Coen, and B. R. Cullen, “MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs,” Nature, vol. 454, no. 7205, pp. 780–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
68. D. M. Pegtel, M. D. B. van de Garde, and J. M. Middeldorp, “Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion,” Biochimica et Biophysica Acta, vol. 1809, no. 11-12, pp. 715–721, 2011. View at Publisher · View at Google Scholar · View at Scopus
69. F. J. Verweij, M. A. J. Van Eijndhoven, E. S. Hopmans et al., “LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation,” The EMBO Journal, vol. 30, no. 11, pp. 2115–2129, 2011. View at Publisher · View at Google Scholar · View at Scopus
70. T. C. Mettenleiter, “Budding events in herpesvirus morphogenesis,” Virus Research, vol. 106, no. 2, pp. 167–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
71. Y. Mori, M. Koike, E. Moriishi et al., “Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway,” Traffic, vol. 9, no. 10, pp. 1728–1742, 2008. View at Publisher · View at Google Scholar · View at Scopus
72. D. M. Pegtel, J. Middeldorp, and D. A. Thorley-Lawson, “Epstein-barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers,” Journal of Virology, vol. 78, no. 22, pp. 12613–12624, 2004. View at Publisher · View at Google Scholar · View at Scopus
73. V. Hadinoto, M. Shapiro, C. C. Sun, and D. A. Thorley-Lawson, “The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output,” PLoS Pathogens, vol. 5, no. 7, Article ID e1000496, 2009. View at Publisher · View at Google Scholar · View at Scopus
74. J. E. Roughan, C. Torgbor, and D. A. Thorley-Lawson, “Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number,” Journal of Virology, vol. 84, no. 2, pp. 1158–1168, 2010. View at Publisher · View at Google Scholar · View at Scopus
75. J. E. Roughan and D. A. Thorley-Lawson, “The intersection of Epstein-Barr virus with the germinal center,” Journal of Virology, vol. 83, no. 8, pp. 3968–3976, 2009. View at Publisher · View at Google Scholar · View at Scopus
76. J. P. Pereira, L. M. Kelly, Y. Xu, and J. G. Cyster, “EBI2 mediates B cell segregation between the outer and centre follicle,” Nature, vol. 460, no. 7259, pp. 1122–1126, 2009. View at Publisher · View at Google Scholar · View at Scopus
77. D. A. Thorley-Lawson and A. Gross, “Persistence of the Epstein-Barr virus and the origins of associated lymphomas,” The New England Journal of Medicine, vol. 350, no. 13, pp. 1328–1337, 2004. View at Publisher · View at Google Scholar · View at Scopus
78. A. D. Hislop, G. S. Taylor, D. Sauce, and A. B. Rickinson, “Cellular responses to viral infection in humans: lessons from Epstein-Barr virus,” Annual Review of Immunology, vol. 25, pp. 587–617, 2007. View at Publisher · View at Google Scholar · View at Scopus
79. D. F. Dukers, P. Meij, M. B. H. J. Vervoort et al., “Direct immunosuppressive effects of EBV-encoded latent membrane protein 1,” The Journal of Immunology, vol. 165, no. 2, pp. 663–670, 2000. View at Scopus
80. J. Li, X. H. Zeng, H. Y. Mo et al., “Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy,” PLoS ONE, vol. 2, no. 11, Article ID e1122, 2007. View at Publisher · View at Google Scholar · View at Scopus
81. H. Vallhov, C. Gutzeit, S. M. Johansson et al., “Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro,” The Journal of Immunology, vol. 186, no. 1, pp. 73–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
82. R. Ruiss, S. Jochum, R. Mocikat, W. Hammerschmidt, and R. Zeidler, “EBV-gp350 confers B-cell tropism to tailored exosomes is a neo-antigen in normal and malignant B cells-a new option for the treatment of B-CLL,” PLoS ONE, vol. 6, no. 10, Article ID e25294, 2011. View at Publisher · View at Google Scholar · View at Scopus
83. S. Pfeffer, M. Zavolan, F. A. Grässer et al., “Identification of virus-encoded microRNAs,” Science, vol. 304, no. 5671, pp. 734–736, 2004. View at Publisher · View at Google Scholar · View at Scopus
84. X. Cai, A. Schäfer, S. Lu et al., “Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed,” PLoS Pathogens, vol. 2, no. 3, article e23, 2006. View at Publisher · View at Google Scholar · View at Scopus
85. R. L. Skalsky, D. L. Corcoran, E. Gottwein et al., “The viral and cellular microRNA targetome in lymphoblastoid cell lines,” PLoS Pathogens, vol. 8, no. 1, Article ID e1002484, 2012. View at Publisher · View at Google Scholar · View at Scopus
86. S. H. Kim, E. R. Lechman, N. Bianco et al., “Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis,” The Journal of Immunology, vol. 174, no. 10, pp. 6440–6448, 2005. View at Scopus
87. D. G. Meckes Jr., K. H. Y. Shair, A. R. Marquitz, C. P. Kung, R. H. Edwards, and N. Raab-Traub, “Human tumor virus utilizes exosomes for intercellular communication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 47, pp. 20370–20375, 2010. View at Publisher · View at Google Scholar · View at Scopus
88. M. I. Yuseff, A. Reversat, D. Lankar et al., “Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation,” Immunity, vol. 35, pp. 361–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
89. N. Izquierdo-Useros, M. C. Puertas, F. E. Borràs, J. Blanco, and J. Martinez-Picado, “Exosomes and retroviruses: the chicken or the egg?” Cellular Microbiology, vol. 13, no. 1, pp. 10–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
90. N. Izquierdo-Useros, M. Naranjo-Gómez, I. Erkizia et al., “HIV and mature dendritic cells: trojan exosomes riding the Trojan horse?” PLoS Pathogens, vol. 6, no. 3, Article ID e1000740, 2010. View at Publisher · View at Google Scholar · View at Scopus
91. N. Onlamoon, K. Pattanapanyasat, and A. A. Ansari, “Human and nonhuman primate lentiviral infection and autoimmunity,” Annals of the New York Academy of Sciences, vol. 1050, pp. 397–409, 2005. View at Publisher · View at Google Scholar · View at Scopus
92. S. J. Gould, A. M. Booth, and J. E. K. Hildreth, “The Trojan exosome hypothesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 19, pp. 10592–10597, 2003. View at Publisher · View at Google Scholar · View at Scopus
93. X. Gan and S. J. Gould, “Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins,” Molecular Biology of the Cell, vol. 22, no. 6, pp. 817–830, 2011. View at Publisher · View at Google Scholar · View at Scopus
94. M. N. Shelton, M.-B. Huang, S. A. Ali, M. D. Powell, and V. C. Bond, “Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release,” Journal of Virology, vol. 86, no. 1, pp. 406–419, 2012. View at Publisher · View at Google Scholar · View at Scopus
95. S. Popov, E. Popova, M. Inoue, and H. G. Göttlinger, “Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid,” Journal of Virology, vol. 82, no. 3, pp. 1389–1398, 2008. View at Publisher · View at Google Scholar · View at Scopus
96. Y. Fang, N. Wu, X. Gan, W. Yan, J. C. Morrell, and S. J. Gould, “Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes,” PLoS Biology, vol. 5, no. 6, article e158, 2007. View at Publisher · View at Google Scholar · View at Scopus
97. A. M. Booth, Y. Fang, J. K. Fallon et al., “Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane,” Journal of Cell Biology, vol. 172, no. 6, pp. 923–935, 2006. View at Publisher · View at Google Scholar · View at Scopus
98. N. Jouvenet, S. M. Simon, and P. D. Bieniasz, “Visualizing HIV-1 assembly,” Journal of Molecular Biology, vol. 410, no. 4, pp. 501–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
99. N. Jouvenet, M. Zhadina, P. D. Bieniasz, and S. M. Simon, “Dynamics of ESCRT protein recruitment during retroviral assembly,” Nature Cell Biology, vol. 13, no. 4, pp. 394–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
100. V. Baumgärtel, S. Ivanchenko, A. Dupont et al., “Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component,” Nature Cell Biology, vol. 13, no. 4, pp. 469–476, 2011. View at Publisher · View at Google Scholar · View at Scopus
101. P. D. Bieniasz, “The cell biology of HIV-1 virion genesis,” Cell Host and Microbe, vol. 5, no. 6, pp. 550–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
102. A. Pelchen-Matthews, G. Raposo, and M. Marsh, “Endosomes, exosomes and Trojan viruses,” Trends in Microbiology, vol. 12, no. 7, pp. 310–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
103. I. W. Park and J. J. He, “HIV-1 is budded from CD4⁺ T lymphocytes independently of exosomes,” Virology Journal, vol. 7, article 234, 2010. View at Publisher · View at Google Scholar · View at Scopus
104. D. G. Nguyen, A. Booth, S. J. Gould, and J. E. K. Hildreth, “Evidence that HIV budding in primary macrophages occurs through the exosome release pathway,” The Journal of Biological Chemistry, vol. 278, no. 52, pp. 52347–52354, 2003. View at Publisher · View at Google Scholar · View at Scopus
105. N. Jouvenet, S. J. Neil, C. Bess et al., “Plasma membrane is the site of productive HIV-1 particle assembly,” PLoS Biology, vol. 4, no. 12, article e435, 2006. View at Publisher · View at Google Scholar · View at Scopus
106. S. Welsch, O. T. Keppler, A. Habermann, I. Allespach, J. Krijnse-Locker, and H. G. Kräusslich, “HIV-1 buds predominantly at the plasma membrane of primary human macrophages,” PLoS Pathogens, vol. 3, no. 3, article e36, 2007. View at Publisher · View at Google Scholar · View at Scopus
107. P. Benaroch, E. Billard, R. Gaudin, M. Schindler, and M. Jouve, “HIV-1 assembly in macrophages,” Retrovirology, vol. 7, article 29, 2010. View at Publisher · View at Google Scholar · View at Scopus
108. M. Deneka, A. Pelchen-Matthews, R. Byland, E. Ruiz-Mateos, and M. Marsh, “In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53,” Journal of Cell Biology, vol. 177, no. 2, pp. 329–341, 2007. View at Publisher · View at Google Scholar · View at Scopus
109. G. Raposo, B. Fevrier, W. Stoorvogel, and M. S. Marks, “Lysosome-related organelles: a view from immunity and pigmentation,” Cell Structure and Function, vol. 27, no. 6, pp. 443–456, 2002. View at Publisher · View at Google Scholar · View at Scopus
110. D. S. Kwon, G. Gregorio, N. Bitton, W. A. Hendrickson, and D. R. Littman, “DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection,” Immunity, vol. 16, no. 1, pp. 135–144, 2002. View at Publisher · View at Google Scholar · View at Scopus
111. N. Izquierdo-Useros, M. Naranjo-Gómez, J. Archer et al., “Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway,” Blood, vol. 113, no. 12, pp. 2732–2741, 2009. View at Publisher · View at Google Scholar · View at Scopus
112. M. Cavrois, J. Neidleman, J. F. Kreisberg, and W. C. Greene, “In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions,” PLoS Pathogens, vol. 3, no. 1, article e4, 2007. View at Publisher · View at Google Scholar · View at Scopus
113. M. Cavrois, J. Neidleman, and W. C. Greene, “The Achilles Heel of the Trojan horse model of HIV-1 trans-infection,” PLoS Pathogens, vol. 4, no. 6, Article ID e1000051, 2008. View at Publisher · View at Google Scholar · View at Scopus
114. H. J. Yu, M. A. Reuter, and D. McDonald, “HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells,” PLoS Pathogens, vol. 4, no. 8, Article ID e1000134, 2008. View at Publisher · View at Google Scholar · View at Scopus
115. B. Brügger, B. Glass, P. Haberkant, I. Leibrecht, F. T. Wieland, and H. G. Kräusslich, “The HIV lipidome: a raft with an unusual composition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2641–2646, 2006. View at Publisher · View at Google Scholar · View at Scopus
116. L. Krishnamoorthy, J. W. Bess, A. B. Preston, K. Nagashima, and L. K. Mahal, “HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin,” Nature Chemical Biology, vol. 5, no. 4, pp. 244–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
117. P. A. Holme, F. Müller, N. O. Solum, F. Brosstad, S. S. FrØland, and P. Aukrust, “Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection,” The FASEB Journal, vol. 12, no. 1, pp. 79–89, 1998. View at Scopus
118. P. Stumptner-Cuvelette, M. Jouve, J. Helft et al., “Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase,” Molecular Biology of the Cell, vol. 14, no. 12, pp. 4857–4870, 2003. View at Publisher · View at Google Scholar · View at Scopus
119. L. J. Costa, N. Chen, A. Lopes et al., “Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1,” Retrovirology, vol. 3, article 33, 2006. View at Publisher · View at Google Scholar · View at Scopus
120. R. Madrid, K. Janvier, D. Hitchin et al., “Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 5032–5044, 2005. View at Publisher · View at Google Scholar · View at Scopus
121. A. Sanfridson, S. Hester, and C. Doyle, “Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 3, pp. 873–878, 1997. View at Publisher · View at Google Scholar · View at Scopus
122. J. L. Goodier and H. H. Kazazian, “Retrotransposons revisited: the restraint and rehabilitation of parasites,” Cell, vol. 135, no. 1, pp. 23–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
123. K. H. Burns and J. D. Boeke, “Great exaptations,” Journal of Biology, vol. 7, no. 2, article 5, 2008. View at Publisher · View at Google Scholar · View at Scopus
124. C. Esnault, J. Maestre, and T. Heidmann, “Human LINE retrotransposons generate processed pseudogenes,” Nature Genetics, vol. 24, no. 4, pp. 363–367, 2000. View at Publisher · View at Google Scholar · View at Scopus
125. K. Ruprecht, H. Ferreira, A. Flockerzi et al., “Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line tera-1 and originate mainly from a provirus on chromosome 22q11.21,” Journal of Virology, vol. 82, no. 20, pp. 10008–10016, 2008. View at Publisher · View at Google Scholar · View at Scopus
126. X. Song, A. Sui, and A. Garen, “Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 2, pp. 621–626, 2004. View at Publisher · View at Google Scholar · View at Scopus
127. S. Boissinot, P. Chevret, and A. V. Furano, “L1 (LINE-1) retrotransposon evolution and amplification in recent human history,” Molecular Biology and Evolution, vol. 17, no. 6, pp. 915–928, 2000. View at Scopus
128. M. K. Konkel, J. Wang, P. Liang, and M. A. Batzer, “Identification and characterization of novel polymorphic LINE-1 insertions through comparison of two human genome sequence assemblies,” Gene, vol. 390, no. 1-2, pp. 28–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
129. I. Martínez-Garay, M. J. Ballesta, S. Oltra et al., “Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome,” Clinical Genetics, vol. 64, no. 6, pp. 491–496, 2003. View at Publisher · View at Google Scholar · View at Scopus
130. J. A. J. M. Van Den Hurk, D. J. R. Van De Pol, B. Wissinger et al., “Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon,” Human Genetics, vol. 113, no. 3, pp. 268–275, 2003. View at Publisher · View at Google Scholar · View at Scopus
131. P. A. Callinan and M. A. Batzer, “Retrotransposable elements and human disease,” Genome Dynamics, vol. 1, pp. 104–115, 2006. View at Scopus
132. R. C. Iskow, M. T. McCabe, R. E. Mills et al., “Natural mutagenesis of human genomes by endogenous retrotransposons,” Cell, vol. 141, no. 7, pp. 1253–1261, 2010. View at Publisher · View at Google Scholar · View at Scopus
133. D. J. Griffiths, “Endogenous retroviruses in the human genome sequence,” Genome Biology, vol. 2, no. 6, article 1017, 2001. View at Scopus
134. K. Boller, K. Schönfeld, S. Lischer et al., “Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles,” Journal of General Virology, vol. 89, no. 2, pp. 567–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
135. B. K. Prusty, H. zur Hausen, R. Schmidt, R. Kimmel, and E. M. de Villiers, “Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells,” Virology, vol. 382, no. 1, pp. 37–45, 2008. View at Publisher · View at Google Scholar · View at Scopus
136. L. Lavie, M. Kitova, E. Maldener, E. Meese, and J. Mayer, “CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2),” Journal of Virology, vol. 79, no. 2, pp. 876–883, 2005. View at Publisher · View at Google Scholar · View at Scopus
137. W. Seifarth, H. Skladny, F. Krieg-Schneider, A. Reichert, R. Hehlmann, and C. Leib- Mosch, “Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences,” Journal of Virology, vol. 69, no. 10, pp. 6408–6416, 1995. View at Scopus
138. D. L. Bronson, E. E. Fraley, J. Fogh, and S. S. Kalter, “Induction of retrovirus particles in human testicular tumor (Tera-1) cell cultures: an electron microscopic study,” Journal of the National Cancer Institute, vol. 63, no. 2, pp. 337–339, 1979. View at Scopus